Interview with Dr. Anahita Keyhani, Altasciences with Mike Lee and Neil Spooner from CPSA Everyday

EPISODE #12 - Transitioning Novel Scientific Workflows To Routine Bioanalysis

As an end-to-end CRO/CDMO, we have expert knowledge in all early stages of drug development, and we’re sharing that knowledge with you in The Altascientist: The Audiobook. 

Each issue is a deep dive into a specific area of early-phase drug development, providing insider tips, considerations, and case studies. 


Altasciences is a drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.

Science

As an end-to-end CRO/CDMO, we have expert knowledge in all early stages of drug development, and we’re sharing that knowledge with you in The Altascientist: The Audiobook. Each issue is a deep dive into a specific area of early-phase drug development, providing insider tips, considerations, and case studies. Altasciences is a drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services.

Share EPISODE #12 - Transitioning Novel Scientific Workflows To Routine Bioanalysis

Sign up to save your podcasts

EPISODE #12 - Transitioning Novel Scientific Workflows To Routine Bioanalysis

EPISODE #12 - Transitioning Novel Scientific Workflows To Routine Bioanalysis